Be sure to stop by the "Picture Booth" Friday or Saturday Morning in the Exhibition Hall to get your headshot updated for the MRS Website.

General Information For Authors

The abstract submission site is open to all trainees, physicians, and Advanced Practice Providers (APPs)

ABSTRACT SUBMISSION DATES:

The online abstract submission site will open on 05/01/2024, and close at 11:59pm, 05/15/2024.

MODIFICATIONS:

Not allowed after final submission

NOTIFICATIONS:

Disposition notifications will be sent to the first author via email on or before 05/18/2024. 

WITHDRAWALS:

The deadline to withdraw an accepted abstract is 5/15/2024, by written request to tguastella@outlook.com. Withdrawal of an accepted abstract after this date or failure to submit a Poster by the deadline may result in the first author and all co-authors’ disqualification from abstract submission for the following MRS Annual Meeting.

SUBJECT CATEGORY:

  1. Clinical Vignette

  2. Research which includes

    1. Basic Research
    2. Clinical Research
    3. High Value Care
    4. Quality Improvement
    5. Patient Safety
    6. Physician Well-being and Professional Fulfillment
    7. Educational

Author Requirements

  • Obtain approval in advance from all co-authors before placing their names on the abstract. Submission of an abstract denotes that co-authors as well as authors have read the abstract, take responsibility for its content and approve that their names appear on the abstract. Failure to obtain approval from all authors will result in immediate rejection of the abstract.
  • A maximum of 10 authors may be listed on each abstract. Authorship credit should only be given if all three of the following criteria are met. Each author must have made substantial contributions to:
    • Conception and design, or analysis and interpretation of data.
    • Drafting the abstract or revising it critically for important intellectual content.
    • Final approval of the version to be submitted/published.
  • Include the affiliation for every author. Spell out the institutions in their entirety and capitalize the first letter of each proper name.
  • Describe experimental methods briefly (including relevant numbers of patients).
  • Ensure that patient confidentiality is protected according to HIPAA regulations.
  • Describe specific findings and analysis of data. Promises such as “to be completed” will not be considered.
  • Include specific conclusions, with supporting statistical analyses when appropriate. Concluding statements such as “the results will be discussed” will not be considered.
  • Refrain from submitting multiple abstracts on overlapping facets of the same project unless each abstract has important, novel information and clearly stands on its own. Repetitive abstracts will be rejected.
  • Remove brand names from the abstract title or body. Use generic terms if referencing a medical device and/or pharmaceutical product.
  • Abstracts that have been presented at other meetings may be submitted for the MRS Annual meeting if it adheres to current MRS Abstract guidelines.
  • Resolve any issues relating to patent matters before submitting the abstract.
  • Agree to the MRS embargo and copyright policies.
  • Disclose any financial interest in accordance with MRS’s disclosure of financial relationships policy. List any financial interests, assistance or relationships with companies, supporters or commercial products that are related to the research (for example: research support, grants, sponsors, stockholder, etc.). Each co-author must complete his/her own financial disclosure and attestation form.
  • Ensure that the first author of an abstract does NOT have a financial interest in the scientific content of the abstract. If the first author has a conflict of interest related to the content, choose a co-author who does not have a relationship to the commercial interests related to the content to be the first author.
  • Inform all co-authors of the status of the submitted abstract. The first author will receive all notifications and communications related to the accepted abstract(s) and is responsible for informing all co-authors of acceptance at the meeting.

Formatting Your Abstract

  • In accordance with HIPAA regulations, patient confidentiality must be protected. Names, dates of scans, birth dates, ages, medical record numbers, zip codes and identities must not be included in the abstract or on images and graphs.
  • The maximum character limit of the abstract is 2,200 including spaces; spaces do count towards the character limit. Use simple fonts.
  • Italicsunderlineboldsuperscript and subscript formatting, Greek characters (both upper and lowercase), scientific characters, charts, tables and graphs are accepted in the body of the abstract only. Do not use these in the title of the abstract.
  • The abstract may contain one small image and one graph. Please include it in the body of your Word or PDF document
  • You may type or copy and paste the text of your abstract from a word processing document or a clipboard directly into the online abstract box or upload your document in the abstract box.
  • Do not send multiple submissions of the same abstract. Duplicate abstracts will be rejected. Be sure to combine all the new information into one abstract.
  • Always keep an original copy of your submitted abstract.
  • Always proofread your abstract. Accepted abstracts will be published exactly as submitted.
  • Institution names should not be included in the title or body of the abstract to keep the review process blind, fair, and objective.
  • The MRS Financial Disclosure Policy:

    all individuals participating as planners, presenters, authors, moderators, and evaluators in an MRS educational activity, or an activity jointly sponsored by the MRS must appropriately disclose any financial relationship with a commercial organization that may have an interest in the content of the educational activity.

All first and co-authors will be required to complete a disclosure form and attest that the statements in the form are accurate, and the abstract complies with the U.S. Government’s Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy and data security standards. Authors must attest that the abstract will adhere to all ACCME Criteria and Standards for Commercial Support.

MRS requires that the first author of an abstract does NOT have a financial interest in the scientific content of the abstract. If the first author has a conflict of interest related to the content, choose a co-author who does not have a relationship to the commercial interests related to the content to attend and answer attendee questions:

  • Attest that there are no third-party ownership or copyright restrictions.
  • Give the MRS permission to record, reproduce and publish the abstract and findings in the meeting program, on the MRS website, in any additional proceedings related to the meeting.

Hold Harmless Clause

Abstract author(s) agrees to bear full responsibility for any claims, damages or losses that may occur because of any acts or omissions made during his or her presentation. The MRS will have no liability for those acts or omissions. However, abstract author(s) will not have any such responsibility if the MRS is proven to be solely negligent.

Embargo Policy

All accepted abstracts submitted to the MRS Annual Meeting are embargoed until the first day of the meeting and therefore, may not be announced, publicized, or distributed before this date.  The first author is responsible for conveying this information to all co-authors. For questions regarding the embargo policy,

Health Insurance Portability and Accountability Act of 1996 (HIPAA)

MRS requires that the content of abstracts submitted to MRS meetings follow the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the U.S. Department of Health and Human Services regulations implementing this act. To comply with HIPAA regulations, patient confidentiality must be maintained in all education presentations.

Members of the Program Committee and education staff will monitor presentations to identify ways to improve overall presentation quality and HIPAA compliance throughout the meeting.

Patient confidentiality must be protected. Names, dates of scans, birth dates, age, zip codes, medical record numbers and identities must not be included on slides, images, or posters that are submitted to MRS. More information on Expert Determination and Safe Harbor can be found on the

Additionally, the abstracts we will have available online for 1 year. Digital copies will be made available on the MRS website.

Returning Member? Please login to check membership status!